ReviewClinical and translational science2022

Adapting regulatory drug-drug interaction guidance to design clinical pharmacokinetic natural product-drug interaction studies: A NaPDI Center recommended approach.

Emily J Cox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.